According to Adicet Bio's latest financial reports the company's current EPS (TTM) is -$2.72. In 2022 the company made an earnings per share (EPS) of -$1.69 an increase over its 2021 EPS that were of -$2.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.72 | 60.95% |
2022 | -$1.69 | -18.36% |
2021 | -$2.07 | -47.74% |
2020 | -$3.96 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | -237.50% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -168.38% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -166.97% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | -26.47% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | $3.31 | -221.69% | ๐บ๐ธ USA |
Quaker Houghton KWR | $0.47 | -117.28% | ๐บ๐ธ USA |